These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25225081)
1. A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Evenepoel P; Cooper K; Holdaas H; Messa P; Mourad G; Olgaard K; Rutkowski B; Schaefer H; Deng H; Torregrosa JV; Wuthrich RP; Yue S Am J Transplant; 2014 Nov; 14(11):2545-55. PubMed ID: 25225081 [TBL] [Abstract][Full Text] [Related]
2. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis. Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931 [TBL] [Abstract][Full Text] [Related]
3. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. Khan A; Bilezikian J; Bone H; Gurevich A; Lakatos P; Misiorowski W; Rozhinskaya L; Trotman ML; Tóth M Eur J Endocrinol; 2015 May; 172(5):527-35. PubMed ID: 25637076 [TBL] [Abstract][Full Text] [Related]
4. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study. Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515 [TBL] [Abstract][Full Text] [Related]
6. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation. Pinho LR; Ribeiro Santos MJ; Pestana Vasconcelos M Clin Nephrol; 2011 Mar; 75(3):263-8. PubMed ID: 21329638 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845 [TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet. Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396 [TBL] [Abstract][Full Text] [Related]
9. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244 [TBL] [Abstract][Full Text] [Related]
10. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807 [TBL] [Abstract][Full Text] [Related]
11. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930 [TBL] [Abstract][Full Text] [Related]
12. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Dong BJ Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445 [TBL] [Abstract][Full Text] [Related]